A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Paladin Labs has entered into a licensing agreement with QRxPharma whereby Paladin received the exclusive rights to market and sell Moxduo, for treating acute pain, in Canada. Read More
Theravance and Merck & Co. have agreed to discover, develop, and commercialize small-molecule therapeutics directed toward a target being investigated for treating of hypertension and heart failure. Read More
Amgen has appointed Cynthia Patton as senior vice-president and chief compliance officer. Read More
Sirona Biochem has named Neil Belenkie as CEO. Read More
Unilife has expanded its commercial development team with the appointment of four senior executives. Read More